Man Group’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-506,499
| Closed | -$40.4M | – | 2177 |
|
|
2021
Q1 | $40.4M | Buy |
506,499
+407,985
| +414% | +$31.9M | 0.18% | 128 |
|
|
2020
Q4 | $7.77M | Buy |
98,514
+81,354
| +474% | +$4.77M | 0.03% | 556 |
|
|
2020
Q3 | $754K | Buy |
+17,160
| New | +$845K | ﹤0.01% | 1445 |
|
|
2019
Q4 | – | Sell |
-69,405
| Closed | -$5.19M | – | 1959 |
|
|
2019
Q3 | $5.19M | Buy |
69,405
+60,738
| +701% | +$5.15M | 0.02% | 853 |
|
|
2019
Q2 | $698K | Sell |
8,667
-1,668
| -16% | -$117K | ﹤0.01% | 1606 |
|
|
2019
Q1 | $691K | Sell |
10,335
-19,947
| -66% | -$1.51M | ﹤0.01% | 1665 |
|
|
2018
Q4 | $2.25M | Sell |
30,282
-84,293
| -74% | -$6.96M | 0.01% | 1162 |
|
|
2018
Q3 | $10.5M | Buy |
114,575
+46,465
| +68% | +$4.43M | 0.04% | 594 |
|
|
2018
Q2 | $6.7M | Buy |
68,110
+58,349
| +598% | +$6.53M | 0.03% | 787 |
|
|
2018
Q1 | $1.09M | Buy |
+9,761
| New | +$1.09M | 0.01% | 1491 |
|
Man Group's CMD Position: Q2 2021 in Review
Man Group sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 506,499 shares — an estimated $40.4M sold.
Man Group first reported a position in CMD in Q1 2018 and held it in 10 quarters. The position peaked at $40.4M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Man Group reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Man Group sold 506,499 Cantel Medical Corporation shares in Q2 2021, an estimated $40.4M.
- Man Group first reported a position in Cantel Medical Corporation in Q1 2018 and held it in 10 quarters.
- Man Group's Cantel Medical Corporation position peaked at $40.4M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Man Group's 13F filing for Q2 2021, filed 16 Aug 2021.